Spain· ES:06960
SULFADIAZINA REIG JOFRE 500 MG COMPRIMIDOS
A sulfadiazine product containing sulfadiazina, registered in Spain by Laboratorio Reig Jofre, S.A.. The same ATC class is registered in 8 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Sulfadiazine is registered in 8 of 19 countries.
Countries holding a registration under ATC J01EC02 (sulfadiazine), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 5 of them publish a price we can compare per daily dose
Sulfadiazine · ATC J01EC02
8 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Japan
- Norwayprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sulfadiazine costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.18 in France to $0.72 in Spain — a ×4.1 gap.
- Spain: $0.72 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Sulfadiazine · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- ES Spain$0.72
- FR France$0.18
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- sulfadiazina
- Manufacturer
- Laboratorio Reig Jofre, S.A.
- Country
- Spain (ES)
- ATC code
- J01EC02
- ATC class
- Sulfadiazine
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 12, 2026
Packs & prices · 1
1 priced- cima_codigo70070920EUR 10.58
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
97 interactions on record for sulfadiazine.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulfadiazine · interactions on record
97 records
- 5 severe
- 61 moderate
- 31 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Aminobenzoic acidD02BA01severe
- Aminolevulinic acidL01XD04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sulfadiazine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomSulfadiazine 500mg tabletsWaymade Healthcare Plc
- United StatessulfADIAZINEChartwell RX, LLC
- FranceADIAZINE 500 mg, compriméBOUCHARA-RECORDATI
- NorwayAdiazineRecordati
- GermanySulfadiazin HeylHeyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Sulfadiazin Heyl
- France · Adiazine
- United Kingdom (Northern Ireland) · Sulfadiazine Wockhardt Uk
- Malta · Sulfadiazine Reig Jofre
- Netherlands · Zilversulfadiazine Sandoz
- Portugal · Labdiazina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/91a7dc44-d5c7-4bee-a136-bccccc797099 GET /v1/drugs/91a7dc44-d5c7-4bee-a136-bccccc797099?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":-770608800000}",
"nregistro": "06960",
"substance": "sulfadiazina"
}See everything about sulfadiazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.